Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose hepatitis B vaccine after interferon-induced HBsAg clearance in chronic hepatitis B
ChiCTR2600127569Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Jul 2026
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of Hepatitis B vaccine in Chronic Hepatitis B (CHB) (2 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoint: HBV DNA at 48 weeks. Started Jul 2026; status: recruiting.
02
Drugs
Hepatitis B vaccine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2600127569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127569.